Dhowaan, Li Haomiao, oo ah agaasimaha Waaxda Kansarka Lafaha ee Isbitaalka Saddexaad ee Xiriirinta ee Jaamacadda Caafimaadka Koonfurta, ayaa dhammaystiray beddelka cilladda hemipelvic ka dib markii burada laga soo saaray LDK sanaaci burada oo habaysan, qalliinkuna si habsami leh ayuu u socday.
Bukaan-socodka waxaa laga helay cufnaanta misigta bidix ee 2007 waxaana lagu maray "dib-u-jaridda burada misigta bidix + tallaalid lafo" isbitaal kale.2010, tirada ayaa soo noqnoqotay oo uu maray "bidix ka-soo-baxa burada lafta lafaha bidix + buuxinta sibidhka lafaha" mar labaad, iyo pathology-ga ka dib waxay muujisay soo noqoshada chondroblastoma.Cisbitaalku waxa uu u soo jeediyay bukaanka in uu aado cusbitaalka takhasuska oncology si loo daawayn dheeraad ah, laakiin bukaanku dheg uma dhigin.
Sanadihii la soo dhaafay, bukaanku wuxuu dareemay xanuunka sii kordhaya ee miskaha bidix, iyo bishii Noofambar 2021, waxaa lagu baaray isbitaal dibadda ah, kaas oo tilmaamaya "kala-baxa sinta bidix iyo ischemic necrosis ee madaxa femoral", oo ay la socdaan isbeddellada morphological iyo calaamadaha miskaha bidix iyo murqaha ku hareeraysan, ischemic necrosis ee madaxa femoral bidix iyo kala-baxa misigta bidix, iyo qanjidhada badan ee qanjidhada oo weyn ee gobolka inguinal bidix.
Daawaynta habaysan ee dheeraadka ah, bukaanku waxa lagu maray "laf-dhabar-goynta halbowlayaasha lugaha hoose ee xubinta taranka ah iyo stenting transurethral-ka-mareenka" iyo "dib-u-jaridda miskaha bidix + arthroplasty bidix + hagaajinta kaadiheysta" Agoosto 2022, oo leh soo kabasho cadaalad ah.
Hadda, bukaanka waxaa ku adag inuu mar kale dhaqaaqo oo xitaa rogo.Dib-u-dhiska miskaha, bukaanku wuxuu u yimid Waaxda Kansarka Lafaha ee Isbitaalka Saddexaad ee Xiriirinta ee Jaamacadda Caafimaadka Koonfurta.
Qalliin ka hor
Ka dib markii Agaasime Li Haomiao uu dhammeeyay baaritaanka la xiriira, wuxuu xaqiijiyay ogaanshaha cilladda hemipelvic ka dib markii la soo saaray burada miskaha bidix.Kooxdu waxay soo abaabushay la tashiyo kala duwan, waxayna dejiyeen qorshe daaweyn qalliin oo kaamil ah, waxay nashqadeeyeen sanaaci la hagaajiyay oo ay la socdeen kooxda LDK oncology, waxayna ugu dambeyntii u fuliyeen qaliinka si habsami leh, qalliinkuna si wanaagsan ayuu u socday.
Sharaxaad:
Bukaan, lab, 31 jir
Cabashada:
Naafonimada dhaqdhaqaaqa in ka badan 7 bilood ka dib kala soocidda tirada miskaha.
Baaritaanno gaar ah:
Nabar qalliin oo 30cm ah ayaa lagu arkay sinta bidix, iyada oo aan lahayn maqaar muuqda ama barar jilicsan, ma dillaacin ama xididdada varicose, dareenka caadiga ah ee labada addin ee hoose, xoogga muruqa caadiga ah ee labada addimada hoose, darajada V, muruqa caadiga ah, durugsan wanaagsan. socodka dhiigga, jilibka laba geesoodka ah ee caadiga ah iyo falcelinta jilibka Achilles, calaamad xun ee Hoffmann, calaamad xun Babinski, calaamad kernig taban.Xubinta ay saamaysay waxay ku dhawaad 3 cm ka gaaban tahay addinka iska soo horjeeda, sinta sinta ayaa aad loo xaddiday, laakiin xubnaha intiisa kale waxay lahaayeen dhaqdhaqaaq dareen oo wanaagsan.
Imtixaannada caawimada:
2022-08-19 CT miskaha: isbeddellada qalliinka kadib ee miskaha bidix.
Cilad-baadhis caafimaad:
1. Cilad Hemipelvic ka dib burada miskaha bidix ee bidix
2. Raaxada ka dib qalliinka
Intrhawlkarnimo
Postoperative
SHordhac dhakhtar
Haamiin LI
Madaxa Waaxda Lafaha Oncology, Dhakhtarka Sare
MD, La-taliye Sare
Dr. qalliinka lafaha oo ka socda Jaamacadda Sun Yat-sen.Waxa maalgalisay Wasaaradda Waxbarashada ee Jamhuuriyadda Shacbiga Shiinaha “Barnaamijka Tababarka Macallinka ee da’da yar ee dibedda” oo uu wax ku bartay Talyaaniga isaga oo wadajira arday heer jaamacadeed ah.Professor Boriani waxa uu baray xirfadaha qalliinka.Waxa uu ku shaqaynayay daawaynta in ka badan 20 sano waxana uu urursaday khibrad qani ah oo ku takhasusay burooyinka lafaha.Waxa uu booqday xarumo badan oo burooyinka lafaha ah oo ku yaal Yurub, Ameerika iyo Japan, iyo xarunta ugu weyn ee burooyinka lafaha ee Shiinaha, Xarunta Burada Lafaha iyo Jilicsan ee Isbitaalka Dadka ee Jaamacadda Peking, si uu wax uga barto awoodaha iskuullada kala duwan ee fikirka.Waxa uu daabacay 8 waraaqo SCI-indexed ah iyo in ka badan 20 warqadood joornaalada asaasiga ah ee gudaha.Waxa la siiyay 4 rukhsad oo loogu talagalay moodooyinka utility iyo 1 patent ee hal-abuurrada.Waxa uu madax ka noqday kana qayb qaatay 5 mashruuc oo heer qaran iyo heer gobol ah.Waxaa lagu abaalmariyay magaca "Yangcheng Good Doctor" ee 2017, "Lingnan Dr Famous Doctor" ee 2017 iyo 2020, "Guangzhou Strong Young Doctors" ee 2018. Waxaa loo doortay "Talentiyada Caafimaadka Da'da yar ee Sare ee Gobolka Guangdong" wuxuuna ku guuleystay labaad Abaalmarinta "Waraaqda Da'da Yar iyo Da'da Dhexe ee aadka u wanaagsan" ee Shirka 20-aad ee Tumor Qaranka ee warqaddiisa "Dhammaan Dib-u-eegidda Qaybaha Isku-dhafka ah ee Lumbosacral Spine Malignant Tumor".
Ballanta Waxbarashada:
Guddoomiye ku xigeenka Qaybta Shiinaha ee Bulshada Caalamiga ah ee Lafaha iyo Traumatology (SICOT) Bulshada Burooyinka Lafaha
Xubin ka tirsan Guddiga Joogtada ah ee Burada Lafaha iyo Guddiga Metastasis ee Lafaha ee Ururka La-dagaallanka Kansarka ee Shiinaha
Xubinta joogtada ah ee Guddiga Sarcoma ee Ururka La-dagaallanka Kansarka ee Shiinaha
Guddoomiye-ku-xigeenka Kooxda Tumor miskaha, Sarcoma Specialized Committee of China Anti-Cancer Association
Guddoomiye-ku-xigeenka Kooxda Tumor-ka laf-dhabarta ee Guddiga Gaarka ah ee Sarcoma ee Ururka Kansarka ee Shiinaha
Xubin Qaran oo ka tirsan Kooxda Burada Lafaha ee Laanta Lafaha ee Ururka Caafimaadka Shiinaha
Agaasimaha Guddiga Dib-u-habaynta Lafaha iyo Dib-u-dhiska ee Ururka Daawada Aasaasiga ah ee Guangdong
Kartida Caafimaadka Da'yarta ee aadka u wanaagsan ee Gobolka Guangdong
Khibrad caafimaad:
burooyinka laf-dhabarta, burooyinka miskaha, burooyinka sacral, burooyinka lafaha cirifka, burooyinka jilicsan ee jilicsan, lafaha lafaha, qalliinka ilaalinta addimada, beddelka miskaha, dib-u-celinta burada sacral, dhammaan xannibaadda (En-bloc) ee burooyinka laf dhabarta.Waxa uu leeyahay guul weyn oo daawaynta ugu yar ee la galmoodka ah ee burooyinka asaasiga ah iyo metastatic ee lafdhabarta.
Waqtiga boostada: Abriil-17-2023